Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis-Reference-Cited by-同舟云学术

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

Published:2020-03 Issue:3 Volume:52 Page:268-273
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Lair-Mehiri Loriane^ORCID,Stefanescu Carmen,Vaysse Thibaut,Laharie David,Roblin Xavier,Rosa Isabelle,Treton Xavier,Abitbol Vered,Amiot Aurélien^ORCID,Bouguen Guillaume,Dib Nina,Fumery Mathurin^ORCID,Pariente Benjamin,Carbonnel Franck,Peyrin-Biroulet Laurent,Simon Marion,Viennot Stéphanie,Bouhnik Yoram

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference20 articles.

1. Natural history of adult ulcerative colitis in population-based cohorts: a systematic review;Fumery;Clin Gastroenterol Hepatol,2018

2. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies;Frolkis;Gastroenterology,2013

3. One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study;Amiot;Aliment Pharmacol Ther,2017

4. Safety of tofacitinib for treatment of ulcerative colitis, based on 4.4 years of data from global clinical trials;Sandborn;Clin Gastroenterol Hepatol,2018

5. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis;Sandborn;N Engl J Med,2012

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis;World Journal of Gastroenterology;2024-09-14

2. Real-world effectiveness and safety of advanced therapies for the treatment of moderate-to-severe ulcerative colitis: Evidence from a systematic literature review;Journal of Managed Care & Specialty Pharmacy;2024-09

3. Tofacitinib in Ulcerative Colitis – Second-Line Therapy, First-Rate Results;Digestive Diseases and Sciences;2024-08-22

4. Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus;Digestive and Liver Disease;2024-08

5. Precision therapy for ulcerative colitis: insights from mitochondrial dysfunction interacting with the immune microenvironment;Frontiers in Immunology;2024-07-04